Symbol="CLNN"
AssetType="Common Stock"
Name="Clene Inc."
Description="Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of new clean-surface nanotechnology (CSN) therapies. The company is headquartered in Salt Lake City, Utah."
CIK="1822791"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="6550 SOUTH MILLROCK DRIVE, SUITE G50, SALT LAKE CITY, UT, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="91175000"
EBITDA="-44579000"
PERatio="None"
PEGRatio="None"
BookValue="-0.021"
DividendPerShare="0"
DividendYield="0"
EPS="-0.37"
RevenuePerShareTTM="0.008"
ProfitMargin="0"
OperatingMarginTTM="-83.28"
ReturnOnAssetsTTM="-0.614"
ReturnOnEquityTTM="-145.3"
RevenueTTM="550000"
GrossProfitTTM="447000"
DilutedEPSTTM="-0.37"
QuarterlyEarningsGrowthYOY="0.614"
QuarterlyRevenueGrowthYOY="2.567"
AnalystTargetPrice="6.43"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="187.08"
PriceToBookRatio="108.2"
EVToRevenue="204.48"
EVToEBITDA="-4.274"
Beta="0.315"
num_52WeekHigh="4.12"
num_52WeekLow="0.64"
num_50DayMovingAverage="0.851"
num_200DayMovingAverage="1.058"
SharesOutstanding="128397000"
DividendDate="None"
ExDividendDate="None"
symbol="CLNN"
open="0.69"
high="0.73"
low="0.68"
price="0.73"
volume="162982.00"
latest_trading_day="2023-08-14"
previous_close="0.72"
change="0.01"
change_percent="1.2849%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="87"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="13"
Volume_recent_avg="401014"
Change_recent_avg="-0.01"
Delta_recent_avg="0.06"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-1.08"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="13"
Aroon_momentum_negative="87"
image_negative_thumbnail_id_1="121"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0055.jpeg"
image_negative_thumbnail_id_2="1132"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0165.jpeg"
image_neutral_thumbnail_id_1="580"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0019.jpeg"
image_neutral_thumbnail_id_2="545"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0054.jpeg"
image_positive_thumbnail_id_1="606"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0102.jpeg"
image_positive_thumbnail_id_2="953"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0115.jpeg"
image_professor_thumbnail_id_1="1182"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
image_professor_thumbnail_id_2="1198"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
